| REGENERON PHARMACEUTICALS | 379.65 / +3.32% |
| Date/Time | 03/05 / 17:32 |
| Chg. / Chg.(%) | 12.20 / +3.32% |
| Bid | - |
| Ask | - |
| Open | 374.25 |
| Previous Close | 367.45 |
| High | 382.25 |
| Low | 370.50 |
| Volume [EUR] | 69,606.45 |
| Volume [Units] | 185 |
| Price fixings | 33 |
| ISIN | US75886F1075 |
| Security | REGN |
| Exchange | Vienna Global Market |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| NASDAQ | 459.8400 |  |
888,093 |
| Cboe US | 460.17 | |
67,428 |
| IEX | 460.77 | |
53,752 |
| TradeGate | 386.000 | |
937 |
| Moscow | 34,061.00 | |
677 |
| Frankfurt | 379.2000 | |
228 |
| Vienna Globa.. | 379.65 | |
185 |
| London Inter.. | 449.63 | |
151 |
| Stuttgart | 383.300 | |
120 |
| Xetra | 381.50 | |
67 |
| München | 381.55 | |
42 |
| gettex | 385.750 | |
29 |
| Hamburg | 373.00 |  |
0 |
| Hannover | 373.00 | |
0 |
| Düsseldorf | 387.00 | |
0 |
| Berlin | 370.30 | |
0 |
| Lang & Schwa.. | 385.70 | |
|
| Mexico | 9,480.00 | |
85 |
News
- FDA accepts Dupixent® (dupilumab) for review in children with moderate-to-severe asthma
03/04/2021 / 07:00 - GlobeNewswire - EMA extends use advice for Regeneron COVID mix
02/26/2021 / 12:28 - TeleTrader - Ziopharm Oncology Provides Leadership and Corporate Updates; Reports Fourth Quarter and Full Year 2020 Financial Results
02/25/2021 / 22:05 - GlobeNewswire - Europe closes lower amid recovery uncertainties
02/25/2021 / 17:31 - TeleTrader - Regeneron: COVID cocktail has clear efficacy
02/25/2021 / 14:13 - TeleTrader
Real-time